T 0781/23 (NKG2A inhibition/Innate) of 30.01.2025
- European Case Law Identifier
- ECLI:EP:BA:2025:T078123.20250130
- Date of decision
- 30 January 2025
- Case number
- T 0781/23
- Petition for review of
- -
- Application number
- 17702315.7
- IPC class
- C07K 16/28A61P 35/00A61K 39/395
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Neutralization of inhibitory pathways in lymphocytes
- Applicant name
- Innate Pharma
- Opponent name
- Høiberg P/S
- Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 100(a)European Patent Convention Art 100(b)European Patent Convention Art 54European Patent Convention Art 56European Patent Convention Art 87
- Keywords
- Patent as granted: Priority - (yes) - presumption of validity
Novelty - (yes)
Inventive step - (yes)
Sufficiency of disclosure - (yes) - Catchword
- -
- Cited cases
- G 0001/21J 0014/19T 0609/02T 0895/13T 2605/18T 2623/18T 0019/20T 0247/20T 0499/20T 0907/20T 1132/22
- Citing cases
- -
Order
For these reasons it is decided that:
The appeal is dismissed.